tiprankstipranks
Advertisement
Advertisement

Rocket Pharmaceuticals reports Q4 EPS (38c), consensus (42c)

Cash position. Cash, cash equivalents and investments as of December 31, 2025, were $188.9 million.

Claim 30% Off TipRanks

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1